A novel hypothesis for the gene expression for the control of atopic and other hereditary diseases  by Okudaira, Hirokazu et al.
Allergology International (1997) 46: 159-160
Hypothesis
A novel hypothesis for the gene expression for the 
control of atopic and other hereditary diseases
Hirokazu Okudaira, Akio Mori, Matsunobu Suko and Koji Ito
Department of Medicine and Physical Therapy, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
ABSTRACT
The requirement of RNA polymerase proteins and 
transcription factor proteins for the expression of 
genetic information in DNA clearly indicates that the 
process is influenced by certain proteins in the body 
and/or in the environment, which is totally opposite to 
the 'central dogma' of Crick. In this article, we present 
a working hypothesis (helical hypothesis) that may 
explain the programmed nature of various biological 
events simply and naturally. Future investigations on 
the factors that regulate the gene transcription of 
cytokine clusters, including intereukin (IL)-4 and IL-5, 
may provide an answer for controlling atopic as well 
as other hereditary (genetic) diseases.
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Atopic diseases have been recognized to be hereditary 
and extensive investigations to identify so-called 'atopy 
genes' have been performed.1-3 An association between 
high serum IgE and the polymorphism in the ƒÀ chain of 
the high-affinity IgE receptor was first described by 
Hopkin and colleagues.1 Marsh and colleagues found 
evidence for linkage of markers on chromosome 5q with 
a gene controlling total serum IgE levels, but not specific 
IgE antibody concentration.2 More recently, Rosenwasser 
and colleagues reported genetic polymorphism in the 
interleukin (IL)-4 promoter gene associated with 
enhanced IgE levels.3 
 We have recently suggested that eosinophilic 
inflammation in atopic diseases, such as chronic
bronchial asthma and atopic dermatitis, may be induced 
by hyperproduction of IL-5, which is the result of enhanced 
IL-5 gene transcription.4-6 In Japan and in Western 
countries, the prevalence of atopic diseases has been 
increasing year by year. For the management of atopic (as 
well as many other genetic) diseases, an understanding 
of the mechanisms of gene expression is mandatory. 
 Genetic information consists of certain series of DNA 
and a fertilized egg develops step-by-step, apparently 
mimicking systemic evolution. In 1958, Crick proposed 
the 'central hypothesis', which suggested that all genetic 
information is transmitted from DNA to RNA and from 
RNA to proteins and never in reverse.7 Findings using 
retroviruses and reverse transcriptase suggest that the 
central hypothesis may not always be compatible. 
Furthermore, it is known that the transcription of DNA is
dependent on signals delivered by certain proteins 
(transcription factors). It is known that there are three 
kinds of RNA polymerase protein that produce RNA using 
DNA as templates.
 In eukaryotic cells, the TATAAA sequence upstream of 
genes often acts as a promoter that determines the 
starting point of transcription. There are many proteins 
with activities different from RNA polymerases but that 
participate in transcription processes and we have termed 
these proteins 'transcription factors'. It is known that 
some proto-oncogene protein products, such as Fos and 
Jun, are actually transcription factors. Gene transcription 
is prominently influenced by the proliferation and 
developmental stage processes of cells, nutrition and the 
micro- and macroenvironments. The existence of RNA 
polymerase proteins and transcription factor proteins 
clearly indicates that the expression of genetic 
information in DNA is influenced by certain proteins and 
environmental factors. 
 The presence of biological phenomena, such as 
enzyme induction, endocrinological feedback system, 
immunological memory (secondary response), growth,
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aging and apoptotic death etc., also clearly suggests that 
expression of genetic information is influenced by certain 
protein molecules and/or environmental factors, which is 
totally opposite to the 'central dogma'. Linearity of the 
central hypothesis gives little understanding of the 
programmed expression of biological events such as 
growth, aging and death. Thus, we have tried to derive a 
working hypothesis (helical hypothesis) that may explain 
the programmed nature of such biological events. The 
helical hypothesis proposes that product(s) of simple and 
primitive organisms induce expression of genes of an 
organism that is, in evolutionary terms, 'one step up', 
acting as transcription factor(s) or creating the
appropriate microenvironment. Continuation of such 
processes would lead to gene expression and 
development of a complex and highly evolved organism, 
such as humans (Fig. 1). 
 The cause of the recent sharp increase in the number 
of atopic patients is unknown at present; however, future 
investigations to identify factors that promote the gene 
transcription of cytokine clusters, including IL-4 and IL-5, 
may provide an answer for controlling atopic as well as 
other hereditary (genetic) diseases.
Fig. 1 Comparison of the central (a) 
and helical (b) hypotheses.
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